You have 9 free searches left this month | for more free features.

City

Anniston (1)

Aventura (1)

Guangzhou (1)

Hangzhou (1)

Pompano Beach (1)

San Antonio (1)

Tampa (1)

Condition

Breast Cancer (1)

Cancer of Prostate (1)

Prostate Cancer (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 3 (1)

Sponsor

Luye Pharma Group Ltd. (3)

Collaborator

Intervention

ly01005 (3)

zoladex® 3.6 mg (2)

zoladex (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

ly01005

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Breast Cancer Trial in Hangzhou (LY01005, ZOLADEX® 3.6 mg)

Recruiting

Breast Cancer

LY01005
ZOLADEX® 3.6 mg

Hangzhou, China

Zhejiang Cancer Hospital

Nov 3, 2021

Prostate Cancer Trial in Guangzhou (LY01005, ZOLADEX® 3.6 mg)

Active, not recruiting

Prostate Cancer

LY01005
ZOLADEX® 3.6 mg

Guangzhou, China

Sun Yat-sen Memorial Hospital of Sun Yat-sen University

Nov 19, 2021

Cancer of Prostate Trial in United States (LY01005, Zoladex)

Completed

Cancer of Prostate

LY01005
Zoladex

Anniston, Alabama
+4 more

Jan 4, 2019